Biodegradation of ibuprofen, diclofenac and carbamazepine in nitrifying activated sludge under 12°C temperature conditions

Science of the Total Environment

Volumn 499, Issue 1, 2014, Pages 394-401

  Kruglova, Antonina ^a   Ahlgren, Pia ^a   Korhonen, Nasti ^a   Rantanen, Pirjo ^a   Mikola, Anna ^a   Vahala, Riku ^a  

^a AALTO UNIVERSITY   (Finland)

Author keywords

Biodegradation rate constant (kbiol); Carbamazepine; Diclofenac; Ibuprofen; Organic loading rate (OLR)

Indexed keywords

BIODEGRADATION RATE; CARBAMAZEPINE; DICLOFENAC; IBUPROFEN; ORGANIC LOADING RATES;

CARBAMAZEPINE; DICLOFENAC; IBUPROFEN; SEWAGE; WATER POLLUTANT;

BIODEGRADATION; CONCENTRATION (COMPOSITION); DRUG; WASTE FACILITY; WASTEWATER;

ACTIVATED SLUDGE; ARTICLE; BIODEGRADATION; BIOREACTOR; CONCENTRATION (PARAMETERS); FINLAND; NITRIFICATION; TEMPERATURE MEASUREMENT; WASTE WATER MANAGEMENT; WATER CONTAMINATION; ANALYSIS; BIOREMEDIATION; CHEMISTRY; COLD; METABOLISM; MICROBIOLOGY; PROCEDURES; SEWAGE; WATER POLLUTANT;

FINLAND;

BIODEGRADATION, ENVIRONMENTAL; CARBAMAZEPINE; COLD TEMPERATURE; DICLOFENAC; FINLAND; IBUPROFEN; NITRIFICATION; SEWAGE; WASTE DISPOSAL, FLUID; WATER POLLUTANTS, CHEMICAL;

EID: 84908108481     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2014.08.069     Document Type: Article

References (34)

1. Abegglen C., Joss A., McArdell C.S., Fink G., Schlüsener M.P., Ternes T.A., et al. The fate of selected micropollutants in a single-house MBR. Water Res 2009, 43:2036-2046.
2. Andreozzi R., Raffaele M., Nicklas P. Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environment. Chemosphere 2003, 50:1319-1330.
3. Barbieri M., Carrera J., Ayora C., Sanchez-Vila X., Licha T., Nödler K., et al. Formation of diclofenac and sulfamethoxazole reversible transformation products in aquifer material under denitrifying conditions: Batch experiments. Sci Total Environ 2012, 426:256-263.
4. Buser H.-R., Poiger T., Müller M.D. Occurrence and environmental behavior of the chiral pharmaceutical drug ibuprofen in surface waters and in wastewater. Environ Sci Tech 1999, 33(15):2529-2535.
5. Clara M., Strenn B., Gans O., Martinez E., Kreuzinger N., Kroiss H. Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants. Water Res 2005, 39(19):4797-4807.
6. Cleuvers M. Aquatic ecotoxicity of pharmaceuticals including the assessment of combination effects. Toxicol Lett 2003, 142:185-194.
7. Donner E., Kosjek T., Qualmann S., Kusk K.O., Heath E., Revitt D.M., et al. Ecotoxicity of carbamazepine and its UV photolysis transformation products. Sci Total Environ 2013, 443:870-876.
8. Falås P., Andersen H.R., Ledin A., la Cour Jansen J. Impact of solid retention time and nitrification capacity on the ability of activated sludge to remove pharmaceuticals. Environ Technol 2012, 33(8):865-872.
9. Ferrari B., Paxéus N., Giudice R.L., Pollio A., Garric J. Ecotoxicological impact of pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid, and diclofenac. Ecotoxicol Environ Saf 2003, 55(3):359-370.
10. Finnish Medicines Agency (FIMEA) Lääkekulutus vuosina 2009-2012 2013, (Helsinki).
11. Fogler S. Elements of chemical reaction engineering 2009, Pearson Education Ltd., Westford.
12. Heberer T. Tracking persistent pharmaceutical residues from municipal sewage to drinking water. J. Hydrol 2002, 266:175-189.
13. Joss A., Zabczynski S., Göbel A., Hoffmann B., Löffler D., McArdell C.S., et al. Biological degradation of pharmaceuticals in municipal wastewater treatment: proposing a classification scheme. Water Res 2006, 40:1686-1696.
14. Kosjek T., Heath E., Kompare B. Removal of pharmaceutical residues in a pilot wastewater treatment plant. Anal Bioanal Chem 2007, 387:1379-1387.
15. Kuronen R. Enhancing wastewater nitrogen removal in activated sludge process by using natural zeolites 2005, Helsinki University of Technology, (Master's Thesis).
16. Lee J., Ji K., Kho Y.L., Kim P., Choi K. Chronic exposure to diclofenac on two cladocerans and Japanese medaka. Ecotoxicol Environ Saf 2011, 74:1216-1225.
17. Lindqvist N., Tuhkanen T., Kronberg L. Occurrence of acidic pharmaceuticals in raw and treated sewages and in receiving waters. Water Res 2005, 39(11):2219-2228.
18. Luo Y., Guo W., Ngo H., Nghiem L.D., Hai F.I., Zhang J., et al. A review on the occurrence of micropollutants in the aquatic environment and their fate and removal during wastewater treatment. Sci Total Environ 2014, 473-474:619-641.
19. Nassef M., Matsumoto S., Seki M., Khalil F., Kang I.J., Shimasaki Y., et al. Acute effects of triclosan, diclofenac and carbamazepine on feeding performance of Japanese medaka fish (Oryzias latipes). Chemosphere 2010, 80:1095-1100.
20. Pomiès P., Choubert J.-M., Wisniewski C., Coquery M. Modelling of micropollutant removal in biological wastewater treatments: a review. Sci Total Environ 2013, 443:733-748.
21. Smolders G.J.F., van der Meij J., van Loosdrecht M.C.M., Heijnen J.J. Model of the anaerobic metabolism of the biological phosphorus removal: stoichiometry and pH influence. Biotechnol Bioeng 1994, 43:461-470.
22. Smook T., Zho H., Zytner R.G. Removal of ibuprofen from wastewater: comparing biodegradation in conventional, membrane bioreactor, and biological nutrient removal treatment systems. Water Sci Technol 2008, 57(1):1-8.
23. Strenn B., Clara M., Gans O., Kreuzinger N. Carbamazepine, diclofenac, ibuprofen and bezafibrate-investigations on the behaviour of selected pharmaceuticals during wastewater treatment. Water Sci Technol 2004, 50:269-276.
24. Suárez S., Lema J.M., Omil F. Removal of pharmaceutical and personal care products (PPCPs) under nitrifying and denitrifying conditions. Water Res 2010, 44:3214-3224.
25. Tauxe-Wuersch A., De Alencastro L.F., Grandjean D., Tarradellas J. Occurrence of several acidic drugs in sewage treatment plants in Switzerland and risk assessment. Water Res 2005, 39(9):1761-1772.
26. Ternes T. Assessment of technologies for the removal of pharmaceuticals and personal care products in sewage and drinking water facilities to improve the indirect potable water reuse. Project acronum POSEIDON 2004.
27. Verlicchi P., Al Aukidy M., Zambello E. Occurrence of pharmaceutical compounds in urban wastewater: removal, mass load and environmental risk after a secondary treatment-a review. Sci Total Environ 2012, 429:123-155.
28. Vieno N., Tuhkanen T., Kronberg L. Seasonal variation in the occurrence of pharmaceuticals in effluents from a sewage treatment plant and in the recipient water. Environ Sci Tech 2005, 39(21):8220-8226.
29. Vieno N.M., Tuhkanen T., Kronberg L. Analysis of neutral and basic pharmaceuticals in sewage treatment plants and in recipient rivers using solid phase extraction and liquid chromatography-tandem mass spectrometry detection. J Chromatogr A 2006, 1134:101-111.
30. Vieno N., Tuhkanen T., Kronberg L. Elimination of pharmaceuticals in sewage treatment plants in Finland. Water Res 2007, 41:1001-1012.
31. Zhang W., Zhang M., Lin K., Sun W., Xiong B., Guo M., et al. Eco-toxicological effect of Carbamazepine on Scenedesmus obliquus and Chlorella pyrenoidosa. Environ Toxicol Pharmacol 2012, 33:344-352.
32. Zorita S., Mårtensson L., Mathiasson L. Occurrence and removal of pharmaceuticals in a municipal sewage treatment system in the south of Sweden. Sci Total Environ 2009, 407:2760-2770.
33. Zwiener C., Frimmel F.H. Short-term tests with a pilot sewage plant and biofilm reactors for the biological degradation of the pharmaceutical compounds clofibric acid, ibuprofen, and diclofenac. Sci Total Environ 2003, 309:201.
34. Zwiener C., Seeger S., Glauner T., Frimmel F.H. Metabolites from the biodegradation of pharmaceutical residues of ibuprofen in biofilm reactors and batch experiments. Anal Bioanal Chem 2002, 372:569-575.